鑫品生醫科技股份有限公司 Approved
最後更新時間 2025/07/11 , 05:00 AM
最後更新時間 2025/07/11 , 05:00 AM
負責人
Zhang,Suo-Zhu
統一編號
27545820
成立日期
2004/12/23
資本額
NT$1,000,000,000
實收資本額
NT$437,713,700
股票代號
4170
電話
#156
地址
6-11F, No. 97, Sec. 1, Sintai 5th Rd., Xizhi Dist., New Taipei City, 221, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Zhang,Suo-Zhu Chairman 13.15%
Cai,Zhang-En Director 1.45%
Meng,Xiang-Yue Director 7.80% HONG PAN INVESTMENT LTD.
Cai,Shi-Xing Director 7.80% HONG PAN INVESTMENT LTD.
Yang,Zong-Xian Independent Director 0.00%
Lai,Bai-Rong Independent Director 0.00%
Tang,Jian-Ming Independent Director 0.00%
營業項目
  • Other Professional, Scientific and Technical Activities Not Elsewhere Classified(760999)
  • 公司歷程
  • Change Person in Charge to Zhang,Suo-Zhu
    2022/07/04
  • Change Person in Charge to Hong,Pan-Tou-Zi-You-Xian-Gong-Si
    2020/08/19
  • Change Capital to 1,000,000,000
    2013/10/23
  • Change Person in Charge to Pan,Jun-You
    2012/05/28
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2024 2023 2022
    Operating income 23,604 55,853 42,913
    Operating cost 19,426 39,430 42,206
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 4,178 16,423 707
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 4,178 16,423 707
    Operating expenses 19,395 32,555 31,244
    Other gain (loss), net - - -
    Operating profit (loss) -15,217 -16,132 -30,537
    Non-operating income and expenses 2,189 9,504 4,084
    Net profit (loss) before tax -13,028 -6,628 -26,453
    Income tax expense (benefits) 0 0 -
    Net profit (loss) of ongoing business for the current period -13,028 -6,628 -26,453
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -13,028 -6,628 -26,453
    Other comprehensive profit (loss), net -908 -3,857 851
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -13,936 -10,485 -25,602
    Net profit (loss) attributable to owners of parent company -13,034 -6,601 -26,412
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests 6 -27 -41
    Comprehensive profit (loss) attributable to owners of parent company -13,965 -10,458 -25,608
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests 29 -27 6
    Basic earnings per share (yuan) 0 0 0
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities -8,043 1,298 14,702
    Net cash inflows (outflows) from investing activities -2,681 -3,819 -26,342
    Net cash inflow (outflow) from financing activities - - 0
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 197 -35 316
    Increase (decrease) in cash and cash equivalents in the current period -10,527 -2,556 -11,324
    Beginning balance of cash and cash equivalents 25,316 27,872 39,196
    Ending balance of cash and cash equivalents 14,789 25,316 27,872
    項目 2024 2023 2022
    Current asset 214,049 223,127 232,063
    Non-current asset 224,194 228,975 233,761
    Total asset 438,243 452,102 465,824
    Current liability 12,697 12,726 15,548
    Non-current liability 8,631 8,525 8,940
    Total liability 21,328 21,251 24,488
    share capital 437,714 437,714 721,404
    Equity - secruity token - - -
    capital reserve 11,666 11,666 101,141
    retained earning -19,635 -6,601 -373,165
    Other equity -13,269 -12,338 -8,481
    Treasury stock - - -
    Total equity attributable to owners of parent company 416,476 430,441 440,899
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 439 410 437
    Total Equity 416,915 430,851 441,336
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 9 9 6
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 肽奇蹟YOUTH MIRACLE設計字
  • 肽極萃POWER EXTRACT設計字
  • 優化免疫細胞銀行 Yuva Immune Cell Bank
  • 鑫品
  • Yuva
  • Yuva
  • VB
  • 鑫品生醫科技 Vectorite Biomedica
  • 鑫諦合
  • Vectorite
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Return investment
    2023
  • Compensation for damage
    2014
  • Compensation for damage, etc.
    2015, 2016, 2017
  • Confirmation of the existence of employment relationship, etc
    2009
  • Pay price
    2016
  • Payment order
    2012, 2014, 2015, 2016
  • Loan repayment
    2014, 2015
  • Pay the ticket
    2012
  • Pay management fee
    2016
  • Petition for trial
    2014
  • Provisional injunction
    2013
  • Compensation for damage, etc.
    2016, 2017
  • Confirmation of the existence of employment relationship, etc
    2009
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。